CNST - Constellation Pharmaceuticals says HSR waiting period expired for its planned sale to MorphoSys
Zhanna Hapanovich/iStock via Getty Images Constellation Pharmaceuticals (CNST) said the waiting period under the HSR act expired for its planned $1.7B sale to MorphoSys (MOR) expired yesterday. Conditions on the offer have been satisfied, according to an 8-K filing. Last month, MorphoSys to acquire Constellation Pharma for $1.7B in cash.
For further details see:
Constellation Pharmaceuticals says HSR waiting period expired for its planned sale to MorphoSys